(Q34383243)

1 August 2017

title

Generation of predictive pharmacophore model for SARS-coronavirus main proteinase (English)

1 reference

1 August 2017

0 references

1 reference

Xue Wu Zhang

1

1 reference

1 August 2017

Yee Leng Yap

series ordinal

2

1 reference

1 August 2017

Ralf M Altmeyer

series ordinal

3

1 reference

1 August 2017

publication date

1 January 2005

1 reference

European Journal of Medicinal Chemistry

1 August 2017

published in

1 reference

1 August 2017

volume

40

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

57-62

1 reference

Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs

1 August 2017

cites work

1 reference

12 December 2020

Novel pharmacophore-based methods reveal gossypol as a reverse transcriptase inhibitor

1 reference

12 December 2020

Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.

1 reference

12 December 2020

HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching

1 reference

12 December 2020

A structure-based design approach for the identification of novel inhibitors: application to an alanine racemase.

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors.

1 reference

12 December 2020

A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides

1 reference

12 December 2020

Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design

1 reference

12 December 2020

Fgl2: link between hepatitis B and SARS?

1 reference

12 December 2020

Generation of Predictive Pharmacophore Models for CCR5 Antagonists: Study with Piperidine- and Piperazine-Based Compounds as a New Class of HIV-1 Entry Inhibitors

1 reference

12 December 2020

Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

1 reference

12 December 2020

Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design

1 reference

12 December 2020

Discovery of HIV-1 integrase inhibitors by pharmacophore searching.

1 reference

12 December 2020

A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community

1 reference

12 December 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

12 December 2020

3-D pharmacophores in drug discovery

1 reference

12 December 2020

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

1 reference

12 December 2020

First pharmacophoric hypothesis for T-type calcium channel blockers

1 reference

12 December 2020

Identification of HIV-1 integrase inhibitors based on a four-point pharmacophore

1 reference

12 December 2020

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

12 December 2020

Comparative pharmacophore development for inhibitors of human and rat 5-alpha-reductase

1 reference

12 December 2020

1 reference

12 December 2020

10.1016/J.EJMECH.2004.09.013

Identifiers

DOI

1 reference

1 August 2017

1 reference